US-based pharmaceutical giant McKesson is setting up a service center in Vilnius.
© DELFI / Domantas Pipas

According to information from the Center of Registers, McKesson Business Services Lithuania was registered on Wednesday with an authorized share capital of 5 million euros and Ildiko By as its CEO.

The new company is wholly owned by McKesson's European unit, Germany-registered McKesson Europe Holdings.

McKesson, one of the largest pharmaceutical businesses in the US, ranked 13th among the world's largest companies by 2018 revenue, next to Apple, Glencore, Samsung and others.

McKesson posted 208.4 billion US dollars in revenue for the 2017-2018 financial year, up 5 percent from 198.5 billion dollars a year earlier.

BNS

Japan plans to involve in Baltic synchronization project

The Baltic states, which are gearing up for the synchronization of their power networks with those...

Lithuanian researchers developed new technology for precision grinding

A team of researchers at Kaunas University of Technology (KTU) has developed a novel approach to...

Real estate tax expansion amendments returned to government

The Seimas of Lithuania lacked several votes on Tuesday to accept a proposal to expand the real...

Energy minister: Lithuania to do all it can to bar Belarus' N-plant electricity

Energy Minister Zygimantas Vaiciunas says Lithuania will take all possible measures to bar market...

Initiative to tax bank assets stalls in Lithuanian parliament

The Lithuanian parliament decided on Tuesday not to debate – at least not for now – a proposal to...